Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101)

NCT02454712 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF614
DRUG: Oxycodone extended-release
DRUG: Naltrexone Hydrochloride

Sponsor

Ensysce Biosciences

Collaborators

[object Object]